Zhejiang Haisen Pharmaceutical's latest marketcap:
As of 07/21/2026, Zhejiang Haisen Pharmaceutical's market capitalization has reached $403.19 M. According to our data, Zhejiang Haisen Pharmaceutical is the 16137th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 403.19 M |
| Revenue (ttm) | 76.98 M |
| Net Income (ttm) | 19.74 M |
| Shares Out | 150.34 M |
| EPS (ttm) | 0.13 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 05/13/2026 |
| Earnings Date | 08/14/2026 |
Zhejiang Haisen Pharmaceutical's yearly market capitalization.
| Date | Market Cap(¥) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/21/2026 | ¥2.73 B | $403.19 M | -5.38% | 16137 |
| 12/31/2025 | ¥3.3 B | $466.64 M | 18.01% | 13876 |
| 12/31/2024 | ¥2.8 B | $382.95 M | -6.46% | 14749 |
| 12/29/2023 | ¥2.99 B | $421.01 M | 14147 |
Company Profile
About Zhejiang Haisen Pharmaceutical Co., Ltd.
Zhejiang Haisen Pharmaceutical Co., Ltd. is a leading Chinese company specializing in the research, development, production, and sale of chemical active pharmaceutical ingredients (APIs) and intermediates. Established in 1998 and headquartered in Dongyang, China, the company serves both domestic and international markets.
Key Offerings
- APIs for therapeutic areas including:
- Anti-gastric ulcer
- Antilipemic agents
- Antipyretic analgesics
- Antidepressants
- Analgesics
- Antibacterial agents
- Histamine drugs
- Anticonvulsants
- Chemical intermediates for pharmaceutical applications
- Food additives for industrial use
With decades of expertise, Zhejiang Haisen Pharmaceutical Co., Ltd. remains committed to delivering high-quality pharmaceutical solutions to global partners.
Frequently Asked Questions
-
What is Zhejiang Haisen Pharmaceutical's (SHE-001367) current market cap?As of 07/21/2026, Zhejiang Haisen Pharmaceutical (including the parent company, if applicable) has an estimated market capitalization of $403.19 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Zhejiang Haisen Pharmaceutical (SHE-001367) rank globally by market cap?Zhejiang Haisen Pharmaceutical global market capitalization ranking is approximately 16137 as of 07/21/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.